Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia
- PMID: 10934283
- PMCID: PMC6772569
- DOI: 10.1523/JNEUROSCI.20-16-06309.2000
Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia
Abstract
Inflammation in the brain has been increasingly associated with the development of a number of neurological diseases. The hallmark of neuroinflammation is the activation of microglia, the resident brain immune cells. Injection of bacterial endotoxin lipopolysaccharide (LPS) into the hippocampus, cortex, or substantia nigra of adult rats produced neurodegeneration only in the substantia nigra. Although LPS appeared to impact upon mesencephalic neurons in general, an extensive loss of dopaminergic neurons was observed. Analysis of the abundance of microglia revealed that the substantia nigra had the highest density of microglia. When mixed neuron-glia cultures derived from the rat hippocampus, cortex, or mesencephalon were treated with LPS, mesencephalic cultures became sensitive to LPS at a concentration as low as 10 ng/ml and responded in a dose-dependent manner with the production of inflammatory factors and a loss of dopaminergic and other neurons. In contrast, hippocampal or cortical cultures remained insensitive to LPS treatment at concentrations as high as 10 microg/ml. Consistent with in vivo observations, mesencephalic cultures had fourfold to eightfold more microglia than cultures from other regions. The positive correlation between abundance of microglia and sensitivity to LPS-induced neurotoxicity was further supported by the observation that supplementation with enriched microglia derived from mesencephalon or cortex rendered LPS-insensitive cortical neuron-glia cultures sensitive to LPS-induced neurotoxicity. These data indicate that the region-specific differential susceptibility of neurons to LPS is attributable to differences in the number of microglia present within the system and may reflect levels of inflammation-related factors produced by these cells.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449006.gif)
![Fig. 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6772569/bin/ns1604449007.gif)
Similar articles
-
Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.J Pharmacol Exp Ther. 2000 May;293(2):607-17. J Pharmacol Exp Ther. 2000. PMID: 10773035
-
Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.J Neurochem. 2002 Jun;81(6):1285-97. doi: 10.1046/j.1471-4159.2002.00928.x. J Neurochem. 2002. PMID: 12068076
-
Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.J Pharmacol Exp Ther. 2000 Oct;295(1):125-32. J Pharmacol Exp Ther. 2000. PMID: 10991969
-
Does lipopolysaccharide-based neuroinflammation induce microglia polarization?Folia Neuropathol. 2020;58(2):113-122. doi: 10.5114/fn.2020.96755. Folia Neuropathol. 2020. PMID: 32729290 Review.
-
The endotoxin hypothesis of neurodegeneration.J Neuroinflammation. 2019 Sep 13;16(1):180. doi: 10.1186/s12974-019-1564-7. J Neuroinflammation. 2019. PMID: 31519175 Free PMC article. Review.
Cited by
-
NLRX1 Inhibits LPS-Induced Microglial Death via Inducing p62-Dependent HO-1 Expression, Inhibiting MLKL and Activating PARP-1.Antioxidants (Basel). 2024 Apr 17;13(4):481. doi: 10.3390/antiox13040481. Antioxidants (Basel). 2024. PMID: 38671928 Free PMC article.
-
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson's Disease?J Parkinsons Dis. 2024;14(2):227-244. doi: 10.3233/JPD-230315. J Parkinsons Dis. 2024. PMID: 38427502 Free PMC article. Review.
-
The role of the placenta-brain axis in psychoneuroimmune programming.Brain Behav Immun Health. 2024 Feb 6;36:100735. doi: 10.1016/j.bbih.2024.100735. eCollection 2024 Mar. Brain Behav Immun Health. 2024. PMID: 38420039 Free PMC article.
-
The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.Mol Neurobiol. 2024 Feb 17. doi: 10.1007/s12035-024-04020-y. Online ahead of print. Mol Neurobiol. 2024. PMID: 38367134
-
The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress.Antioxidants (Basel). 2024 Jan 22;13(1):132. doi: 10.3390/antiox13010132. Antioxidants (Basel). 2024. PMID: 38275657 Free PMC article. Review.
References
-
- Arditi M, Manogue KR, Caplan M, Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis. 1990;162:139–147. - PubMed
-
- Boje KM, Arora PK. Microglia-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992;587:250–256. - PubMed
-
- Bronstein DM, Perez-Otano I, Sun V, Mullis Sawin SB, Chan J, Wu G-C, Hudson PM, Kong L-Y, Hong J-S, McMillian MK. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 1995;704:112–116. - PubMed
-
- Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci. 1994;16:152–161. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources